Free Webinar - Advances in Drug Discovery: Fragmented-based Drug Discovery

Webinar: Fragment-based Drug Discovery: From inception to drug, the evolution of the tools that enabled Bcl-2 drug discovery and Venclexta approval.

Thursday 1st September 2016 | 4 pm GMT

Hosted by Vincent Stoll, Associate Director of Structural Biology, Abbvie

 • Discussion about the origins of Fragment-based drug Discovery driven by the need to discover drugs for the Bcl-2 protein
 • New approach, fragment-based drug discovery
 • Process and technologies of fragment-based drug Discovery and how they have evolved since the start of the Bcl-2 program
 • Expanding the approaches to fragment screening, significant advances in speed and quality of protein X-ray crystal structure information and integration of chemistry

Register for free today: https://attendee.gotowebinar.com/register/6129414862522010883

Benefits to Attending:
 • Advance your knowledge on Fragmented-based Drug Discovery
 • Hear about the latest the approaches to fragment screening
 • Learn from a leading expert about his experience in Drug Discovery
 • Hear about an innovative approach for Venclexta, a treatment of lymphocytic leukemia